ATE555776T1 - Feste arzneiform, die eine feste dispersion enthält, und verfahren zur herstellung derselben - Google Patents

Feste arzneiform, die eine feste dispersion enthält, und verfahren zur herstellung derselben

Info

Publication number
ATE555776T1
ATE555776T1 AT07015395T AT07015395T ATE555776T1 AT E555776 T1 ATE555776 T1 AT E555776T1 AT 07015395 T AT07015395 T AT 07015395T AT 07015395 T AT07015395 T AT 07015395T AT E555776 T1 ATE555776 T1 AT E555776T1
Authority
AT
Austria
Prior art keywords
solid
producing
solid dispersion
dispersion
disintegrant
Prior art date
Application number
AT07015395T
Other languages
English (en)
Inventor
Fumie Kusaki
Takafumi Hoshino
Naosuke Maruyama
Yuichi Nishiyama
Ikuo Fukui
Hiroshi Umezawa
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Application granted granted Critical
Publication of ATE555776T1 publication Critical patent/ATE555776T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07015395T 2006-08-08 2007-08-06 Feste arzneiform, die eine feste dispersion enthält, und verfahren zur herstellung derselben ATE555776T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006215401 2006-08-08
JP2006287859 2006-10-23

Publications (1)

Publication Number Publication Date
ATE555776T1 true ATE555776T1 (de) 2012-05-15

Family

ID=38520550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07015395T ATE555776T1 (de) 2006-08-08 2007-08-06 Feste arzneiform, die eine feste dispersion enthält, und verfahren zur herstellung derselben

Country Status (6)

Country Link
US (1) US8343547B2 (de)
EP (1) EP1886672B1 (de)
KR (1) KR101136659B1 (de)
CN (1) CN103070838B (de)
AT (1) ATE555776T1 (de)
TW (1) TWI468178B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2837639B1 (de) * 2013-08-12 2020-02-26 Shin-Etsu Chemical Co., Ltd. Verfahren zum Entwässern von wasserhaltiger niedersubstituierter Hydroxypropylzellulose und Verfahren zur Herstellung von niedrigsubstituierter Hydroxypropylzellulose damit
CN104546666A (zh) * 2013-10-18 2015-04-29 博瑞生物医药技术(苏州)有限公司 一种非达霉素固体分散体及其制备方法
BR112018008308A2 (pt) * 2015-10-30 2018-10-30 Toray Industries micropartícula do derivado de celulose, dispersão, método para a produção da micropartícula, micropartícula compósita e preparação
WO2017091373A1 (en) * 2015-11-25 2017-06-01 Patheon Development Services Inc. Amorphous dispersion granules and oral dosage forms
WO2017130709A1 (ja) * 2016-01-29 2017-08-03 小林　光 固形製剤、固形製剤の製造方法及び水素発生方法
KR102469464B1 (ko) 2016-10-07 2022-11-22 신에쓰 가가꾸 고교 가부시끼가이샤 저치환도 히드록시프로필 셀룰로오스 및 그의 제조 방법, 및 고형 제제
KR102498064B1 (ko) 2016-10-07 2023-02-10 신에쓰 가가꾸 고교 가부시끼가이샤 저치환도 히드록시프로필 셀룰로오스 및 그의 제조 방법, 및 고형 제제

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852421A (en) 1970-03-23 1974-12-03 Shinetsu Chemical Co Excipient and shaped medicaments prepared therewith
JPS5163927A (en) 1974-11-28 1976-06-02 Shinetsu Chemical Co Ketsugoseiryokonajozaihokaizaino seizohoho
DE3236416A1 (de) * 1982-10-01 1984-04-05 Licentia Patent-Verwaltungs-Gmbh, 6000 Frankfurt Verfahren zur qualitaetsbeurteilung von stahloberflaechen
US5028433A (en) * 1988-11-30 1991-07-02 Banyu Pharmaceutical Co., Ltd. Readily absorbable drug formulation of NB-818
HU209564B (en) 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
DK0662320T3 (da) 1991-08-30 2001-09-24 Showa Pharm Chem Ind Tør gelsammensætning
US5340591A (en) 1992-01-24 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
JP2994956B2 (ja) 1994-05-31 1999-12-27 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース、その組成物およびその錠剤
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
JP3001401B2 (ja) 1995-09-19 2000-01-24 信越化学工業株式会社 セルロースエーテルの粉末化方法およびセルロースエーテルの粉末化装置
AU717817B2 (en) 1996-06-06 2000-04-06 Bifodan A/S Enteric coating, comprising alginic acid, for an oral preparation
JP3212534B2 (ja) * 1997-04-08 2001-09-25 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース粉末
JP3408398B2 (ja) 1997-05-09 2003-05-19 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース粉末の製造方法
JP3799134B2 (ja) * 1997-05-28 2006-07-19 ソニー株式会社 システムおよび通知方法
US6396509B1 (en) * 1998-02-21 2002-05-28 Koninklijke Philips Electronics N.V. Attention-based interaction in a virtual environment
US6380952B1 (en) * 1998-04-07 2002-04-30 International Business Machines Corporation System for continuous display and navigation in a virtual-reality world
JP3718341B2 (ja) 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
US6782374B2 (en) * 1998-12-22 2004-08-24 Accenture Global Services Gmbh System, method and article of manufacturing for a runtime program analysis tool for a simulation engine
EG23951A (en) 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
EP1054019A1 (de) * 1999-05-18 2000-11-22 Shin-Etsu Chemical Co., Ltd. Niedersubstituierte Hydroxypropylcellulose
JP2001009316A (ja) 1999-06-29 2001-01-16 Shin Etsu Chem Co Ltd パルプの粉末化方法及びセルロースエーテルの製造方法
US6680069B1 (en) 1999-11-09 2004-01-20 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose and process for manufacturing the same
DE60110666T2 (de) * 2000-03-17 2006-02-02 Shin-Etsu Chemical Co., Ltd. Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
KR100496749B1 (ko) * 2000-07-05 2005-06-22 아사히 가세이 가부시키가이샤 셀룰로스 분말
US7036082B1 (en) * 2000-09-21 2006-04-25 Nortel Networks Limited Controlling communications through a virtual reality environment
US6910186B2 (en) * 2000-12-08 2005-06-21 Kyunam Kim Graphic chatting with organizational avatars
US7009046B2 (en) 2001-12-11 2006-03-07 Shin-Etsu Chemical Co. Ltd. Low-substituted hydroxypropyl cellulose and agent serving both as binder and disintegrant for dry direct compression
WO2003063831A2 (en) 2002-02-01 2003-08-07 Pfizer Products Inc. Immediate release dosage forms containing solid drug dispersions
US6995144B2 (en) * 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
TW200404544A (en) 2002-06-17 2004-04-01 Kowa Co Controlled release pharmaceutical composition
JP2004067606A (ja) 2002-08-08 2004-03-04 Zensei Yakuhin Kogyo Kk イトラコナゾール経口投与製剤
KR100592511B1 (ko) 2002-12-30 2006-07-03 안경섭 벤즈이미다졸 유도체 또는 약리학적으로 허용되는 이의염을 활성물질로 하는 안정성이 강화된 방출제어형 제제및 그 제조방법
US7913176B1 (en) * 2003-03-03 2011-03-22 Aol Inc. Applying access controls to communications with avatars
CN100563658C (zh) * 2003-11-14 2009-12-02 味之素株式会社 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂
EP1854463A4 (de) 2005-03-03 2011-03-23 Takeda Pharmaceutical Zusammensetzung mit kontrollierter freisetzung
US8486450B2 (en) 2005-12-28 2013-07-16 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
US20100226979A1 (en) 2006-03-21 2010-09-09 Jubilant Organosys Limited Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate

Also Published As

Publication number Publication date
TWI468178B (zh) 2015-01-11
CN103070838A (zh) 2013-05-01
US8343547B2 (en) 2013-01-01
EP1886672A2 (de) 2008-02-13
EP1886672B1 (de) 2012-05-02
KR20080013777A (ko) 2008-02-13
TW200815034A (en) 2008-04-01
EP1886672A3 (de) 2009-11-04
CN103070838B (zh) 2014-12-31
KR101136659B1 (ko) 2012-04-18
US20080038339A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
ATE529098T1 (de) Feste arzneiform einer darmlöslichen dispersion und verfahren zur herstellung derselben
ATE555776T1 (de) Feste arzneiform, die eine feste dispersion enthält, und verfahren zur herstellung derselben
JP7637616B2 (ja) 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形
Maniruzzaman et al. A review of hot‐melt extrusion: process technology to pharmaceutical products
WO2010053335A2 (ko) 난용성 약물의 나노입자를 포함하는 분말의 제조방법, 그에 의해 제조된 분말 및 이를 포함하는 약학적 조성물
CN109475504B (zh) 剂型
AU2025203284A1 (en) Rapidly disintegrating oral film matrix
DE69936430D1 (de) Verfahren zur Herstellung von in der Mundhöhle rasch zerfallenden Tabletten
EP3544592A1 (de) Feste pharmazeutische darreichungsformen und verfahren
JP2017533914A (ja) 胃内滞留性ゲル製剤
Park et al. Fabrication and characterization of dissolving microneedle arrays for improving skin permeability of cosmetic ingredients
CA2599617A1 (en) Drug formulations having improved pharmacokinetic properties
TW200640502A (en) Tablets with improved drug substance dispersibility
Almeida et al. Hot-melt extrusion developments in the pharmaceutical industry
JP2016507579A (ja) 経口投与用の咀嚼可能な組成物およびその製造方法
Leonardi et al. Multiresponse optimization of the properties of albendazole–chitosan microparticles
CA2599649A1 (en) Drug formulations having controlled bioavailability
EP2822538A1 (de) Herstellung von pharmazeutischen protektiven überzügen mit guter resistenz im neutralen milieu
CN115380006A (zh) 用于生产自由流动粒状物的方法
JP2022504958A (ja) 活性物質の放出速度の制御を可能にする、前記活性物質を封入するための脂質組成物
Chowdary et al. A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF IRBESARTAN BY SOLID DISPERSION IN STARCH PHOSPHATE AND GELUCIRE
JP2009219533A (ja) 皮膚レプリカ作製用の組成物キット
Maschke et al. Effect of Preparation Method on Release Behavior of Kollidon SR Tablets Hot Melt Extrusion versus Direct Compression
JP2013159582A (ja) 錠剤の製造方法および錠剤
JP2014031332A (ja) マークが施された圧縮成形体の製造方法